These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal Bevacizumab with or without Triamcinolone for Wet Age-related Macular Degeneration: Twelve-month Results of a Prospective, Randomized Investigation. Motarjemizadeh Q; Aidenloo NS; Abbaszadeh M; Sadrinia V Middle East Afr J Ophthalmol; 2018; 25(1):1-7. PubMed ID: 29899643 [TBL] [Abstract][Full Text] [Related]
10. Role of vascular endothelial growth factor polymorphisms in the treatment success in patients with wet age-related macular degeneration. Boltz A; Ruiß M; Jonas JB; Tao Y; Rensch F; Weger M; Garhöfer G; Frantal S; El-Shabrawi Y; Schmetterer L Ophthalmology; 2012 Aug; 119(8):1615-20. PubMed ID: 22521084 [TBL] [Abstract][Full Text] [Related]
11. The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy. Bakri SJ; Larson TA Semin Ophthalmol; 2015 Jul; 30(4):276-80. PubMed ID: 24251435 [TBL] [Abstract][Full Text] [Related]
12. Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy. Sakai T; Ohkuma Y; Kohno H; Hayashi T; Watanabe A; Tsuneoka H Br J Ophthalmol; 2014 Dec; 98(12):1642-8. PubMed ID: 25053762 [TBL] [Abstract][Full Text] [Related]
13. Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration. Smailhodzic D; Muether PS; Chen J; Kwestro A; Zhang AY; Omar A; Van de Ven JP; Keunen JE; Kirchhof B; Hoyng CB; Klevering BJ; Koenekoop RK; Fauser S; den Hollander AI Ophthalmology; 2012 Nov; 119(11):2304-11. PubMed ID: 22840423 [TBL] [Abstract][Full Text] [Related]
14. Triple therapy for anti-vascular endothelial growth factor nonresponders in neovascular age-related macular degeneration: impact of different photodynamic therapy parameters. Veritti D; Lanzetta P Ophthalmologica; 2013; 230(3):131-7. PubMed ID: 23948986 [TBL] [Abstract][Full Text] [Related]
15. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration. Ahmadieh H; Taei R; Soheilian M; Riazi-Esfahani M; Karkhaneh R; Lashay A; Azarmina M; Dehghan MH; Moradian S BMC Ophthalmol; 2007 Jun; 7():10. PubMed ID: 17555600 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab alone versus in combination with photodynamic therapy for the treatment of neovascular maculopathy in patients aged 50 years or older: 1-year results of a prospective clinical study. Lim JY; Lee SY; Kim JG; Lee JY; Chung H; Yoon YH Acta Ophthalmol; 2012 Feb; 90(1):61-7. PubMed ID: 20337606 [TBL] [Abstract][Full Text] [Related]
18. Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone. Yip PP; Woo CF; Tang HH; Ho CK Br J Ophthalmol; 2009 Jun; 93(6):754-8. PubMed ID: 19273471 [TBL] [Abstract][Full Text] [Related]
19. CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration. McKibbin M; Ali M; Bansal S; Baxter PD; West K; Williams G; Cassidy F; Inglehearn CF Br J Ophthalmol; 2012 Feb; 96(2):208-12. PubMed ID: 21558292 [TBL] [Abstract][Full Text] [Related]
20. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema. Liu Q; Hu Y; Yu H; Yuan L; Hu J; Atik A; Guan M; Li D; Li X; Tang S Retina; 2015 Feb; 35(2):272-9. PubMed ID: 25105313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]